Deliverable Number | Deliverable title | Delivery date (month after start of project) | Corresponding workpackage | Responsible participant |
1 | Report on sampling site selection | 3 | WP1 | 2 |
2 | Ambient PM sampling (ISAAC-2) | 4-18 | WP1 | 2 |
3 | Additional ambient, diesel and gasoline PM sampling and characterisations of all PM | 6-30 | WP1 | 6 |
4 | In-vitro tox screened PM | 7-24 | WP2 | 3 |
5 | In-vitro screened PM with tox contrasts selected for animal tox screening | 15-18 | WP2 | 3 |
6 | PM oxidative capacity | 24 | WP3 | 3 |
7 | Signalling mechanisms in cells exposed to PM | 36 | WP3 | 4 |
8 | In-vivo animal tox screened PM | 27 | WP4 | 6 |
9 | Overall composition/source-tox evaluation | 34 | WP7 | 6 |
10 | DE and gasoline PM effects in humans | 21 | WP5 | 1 |
11 | DE effects in asthmatics evaluated with less invasive techniques | 24 | WP6 | 1 |
12 | DE effects in COPD evaluated with less invasive techniques | 27 | WP6 | 1 |
13 | Planning for statistical ambient PM composition/source – toxicity-health effect evaluation linked to epidemiological ISAAC-2 study | 30 | WP7 | 2 |
14 | Report from statistical evaluation of ambient PM composition/source – toxicity-health effect evaluation linked to epidemiological ISAAC-2 study | 36 | WP7 | 2 |
